Stifel maintains Philip Morris Intl at Buy, raises price target to $232 from $205

Stifel kept its Buy rating on Philip Morris Intl and increased its price target to $232 from $205, suggesting an 11.4% upside from the Nov 2 close. Other recent analyst targets for the company range from $201 to $220.

Original reporting
Published Nov 3, 2026, 1:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 1:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stifel maintains Philip Morris Intl at Buy, raises price target to $232 from $205 — source image
Decision brief

The 30-second read

$PMBullishLow
01

Why it matters

The higher target may attract new buying interest and support the stock price.

02

Market read

Analyst target revisions are a common driver of short‑term price moves in large‑cap stocks.

03

What to watch

Potential impact of e‑cigarette competition and global tax pressures are not addressed.

Relevance 6/10Novelty 6/10Timing: today

Background

Stifel's rating upgrade follows a period of stable performance for Philip Morris International.

Company-level read

Ticker impact

$PMBullishMedium confidence
Context

Stifel raised its price target for Philip Morris International to $232 from $205, indicating a new bullish outlook.

Expected impact

likely upward pressure as the market absorbs the higher target

Evidence & confidence

Target raise is a fresh analyst action; no other catalyst is mentioned.

Market effects

May lift other tobacco peers as the sector is viewed more favorably.

Limited to US and European markets where Philip Morris trades.

Minor, confined to tobacco industry investors.

Counterpoint

The target raise could be premature if regulatory risks or declining smoking rates intensify.

Key entities

  • Philip Morris International

    Global tobacco company listed on NYSE under ticker PM.

  • Stifel

    Equity research firm that issued the rating upgrade.

Related articles

$PMHighAI 8/10

PMI reports third-quarter 2026 net revenue topped $11.4B

Philip Morris International (PMI) reported third-quarter 2026 net revenue of $11.4B, with smoke-free products making up over 40%. Zyn shipments grew 4.2% to 3.2B pouches. The FDA authorized 11 more Zyn Ultra variants, totaling 31. PMI plans to invest more in Zyn and transition to 20-pouch cans.

$PMMedAI 8/10

Philip Morris International Inc (PM) (Q3 2026) Earnings Call Highlights: Record $5

Philip Morris International (PM) reported Q3 2026 results with organic net revenue growth of 7.1% and adjusted operating income growth of 10.5%, exceeding $5 billion. Smoke-free products drove growth, with IQOS and Veev shipments up. The company faces cost pressures from geopolitical conflicts, impacting full-year EPS growth. Guidance was lowered to the midpoint or lower half of the range. Operating cash flow is expected to reach approximately $13.5 billion.

$THighAI 8/10

AT&T Raises 2026 Outlook as Dell AI Adoption Tops 6,500

AT&T reported Q3 revenue growth of 5.3% to $32.3B, raised 2026 adjusted EPS outlook to ~$2.40. Philip Morris saw Q3 revenue rise 5.5% to $11.4B, adjusted EPS up 5.4% to $2.36. Moody's reported 1% revenue growth to $2.023B, reaffirmed 2026 adjusted EPS forecast of $16.50-$17.00. Dell announced AI adoption by 6,500 enterprises.